Movano Inc. MOVE
We take great care to ensure that the data presented and summarized in this overview for Movano Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in MOVE
Top Purchases
Top Sells
About MOVE
Movano Inc. engages in developing a platform to deliver healthcare solutions at the intersection of medtech and consumer devices. Its platform uses radiofrequency technology, which enables the creation of sensors that are small enough to fit into wearable devices and other small form factors. The company develops Movano Ring that measures heart rate, heart rate variability, sleep, respiration, temperature, blood oxygen saturation, steps, and calories, as well as incorporates women-centric features and design. It is also developing non-invasive continuous glucose monitoring and cuffless blood pressure monitoring features to its technology platform. The company was formerly known as Maestro Sensors Inc. and changed its name to Movano Inc. in August 2018. Movano Inc. was incorporated in 2018 and is based in Pleasanton, California.
Insider Transactions at MOVE
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 03
2025
|
Shaheen Wirk |
SELL
Sale (or disposition) back to the issuer
|
Direct |
6,841
-100.0%
|
-
|
|
Nov 03
2025
|
Ruben Caballero |
SELL
Sale (or disposition) back to the issuer
|
Direct |
8,295
-93.94%
|
-
|
|
Nov 03
2025
|
Emily Fairbairn |
SELL
Sale (or disposition) back to the issuer
|
Direct |
12,442
-82.22%
|
-
|
|
Nov 03
2025
|
Brian Cullinan |
SELL
Sale (or disposition) back to the issuer
|
Direct |
13,271
-87.63%
|
-
|
|
Nov 03
2025
|
Jeremy Cogan CFO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
31,871
-85.96%
|
-
|
|
Nov 03
2025
|
Michael Aaron Leabman Chief Technology Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
21,260
-98.35%
|
-
|
|
Nov 03
2025
|
John Mastrototaro Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
39,226
-95.28%
|
-
|
|
Oct 03
2025
|
Emily Fairbairn |
BUY
Grant, award, or other acquisition
|
Direct |
31,028
+17.02%
|
-
|
|
Oct 03
2025
|
Jeremy Cogan CFO |
BUY
Grant, award, or other acquisition
|
Direct |
134,456
+26.61%
|
-
|
|
Oct 03
2025
|
John Mastrototaro Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
165,484
+28.67%
|
-
|
|
Oct 03
2025
|
Ruben Caballero |
BUY
Grant, award, or other acquisition
|
Direct |
20,685
+18.98%
|
-
|
|
Oct 03
2025
|
Brian Cullinan |
BUY
Grant, award, or other acquisition
|
Direct |
33,096
+17.93%
|
-
|
|
Oct 03
2025
|
Shaheen Wirk |
BUY
Grant, award, or other acquisition
|
Direct |
20,685
+23.22%
|
-
|
|
Jul 03
2025
|
Jeremy Cogan CFO |
BUY
Grant, award, or other acquisition
|
Direct |
121,272
+33.92%
|
-
|
|
Jul 03
2025
|
Emily Fairbairn |
BUY
Grant, award, or other acquisition
|
Direct |
27,985
+18.87%
|
-
|
|
Jul 03
2025
|
John Mastrototaro Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
149,257
+37.74%
|
-
|
|
Jul 03
2025
|
Brian Cullinan |
BUY
Grant, award, or other acquisition
|
Direct |
29,851
+20.14%
|
-
|
|
Jul 03
2025
|
Ruben Caballero |
BUY
Grant, award, or other acquisition
|
Direct |
18,657
+21.63%
|
-
|
|
Jul 03
2025
|
Shaheen Wirk |
BUY
Grant, award, or other acquisition
|
Direct |
18,657
+28.1%
|
-
|
|
Jul 03
2025
|
Michael Aaron Leabman Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
139,925
+39.3%
|
-
|
Last 12 Months Summary
| Grant, award, or other acquisition | 1.33M shares |
|---|
| Sale (or disposition) back to the issuer | 133K shares |
|---|